Eva Gunnel Johanna Öberg,
Rolf Jorde,
Yngve Anton Figenschau,
Per Medbøe Thorsby,
Sandra Rinne Dahl,
Anne Winther
et al.:
Combined hormonal contraceptives and vitamin D metabolism in adolescent girls
Rolf Jorde,
Julia Magdalena Kubiak,
Johan Svartberg,
Ole-Martin Fuskevåg,
Yngve Anton Figenschau,
Ieva Martinaityte
et al.:
Vitamin
D
supplementation
has
no
e
ffect
on
cognitive
performance
after
four
months
in
mid-aged
and
older
subjects
Journal of the Neurological Sciences 2019
DOI
Ragnhild Sørensen Høifødt,
Knut Waterloo,
Catharina Elisabeth Arfwedson Wang,
Martin Eisemann,
Yngve Anton Figenschau,
Marianne Halvorsen
:
Cortisol levels and cognitive profile in major depression: A comparison of currently and previously depressed patients
Psychoneuroendocrinology 22. August 2018
ARKIV /
DOI
Magne Flaten,
Espen Bjørkedal,
Peter Solvoll Lyby,
Yngve Anton Figenschau,
Per M Aslaksen
:
Failure to Find a Conditioned Placebo Analgesic Response.
Frontiers in Psychology 30. July 2018
ARKIV /
DOI
Ann Kristin Hansen,
Yngve Anton Figenschau,
Inigo Zubiavrre Martinez
:
Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes
BMC Musculoskeletal Disorders 2017
ARKIV /
DOI
Stina Therese Sollid,
Moira Strand Hutchinson,
Vivian Berg,
Ole-Martin Fuskevåg,
Yngve Anton Figenschau,
Per Medbøe Thorsby
et al.:
Effects of Vitamin D binDing protein phenotypes and Vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
European Journal of Endocrinology (EJE) 2016
ARKIV /
DOI
Rolf Jorde,
Stina Therese Sollid,
Johan Svartberg,
Henrik Schirmer,
Ragnar Martin Joakimsen,
Inger Njølstad
et al.:
Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes
Journal of Clinical Endocrinology and Metabolism (JCEM) 2016
DOI
Igor Snapkov,
Carl Otto Öqvist,
Yngve Anton Figenschau,
Per Kogner,
John Inge Johnsen,
Baldur Sveinbjørnsson
:
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
Ann Kristin Hansen,
Jill-Tove Indrevik,
Yngve Anton Figenschau,
Inigo Zubiavrre Martinez,
Baldur Sveinbjørnsson
:
Human articular chondrocytes express functional leukotriene B<sub>4</sub> receptors
Stina Therese Sollid,
Moira Strand Hutchinson,
Ole-Martin Fuskevåg,
Yngve Anton Figenschau,
Ragnar Martin Joakimsen,
Henrik Schirmer
et al.:
No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes
Rolf Jorde,
Henrik Schirmer,
Tom Wilsgaard,
Ragnar Martin Joakimsen,
Ellisiv B. Mathiesen,
Inger Njølstad
et al.:
The phosphodiesterase 8B Gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: The Tromsø study
Martin Solvang Johnsen,
Guri Grimnes,
Yngve Anton Figenschau,
Peter A Torjesen,
Bjørg Almås,
Rolf Jorde
:
Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D
Scandinavian Journal of Clinical and Laboratory Investigation 2014
DOI
Moira Strand Hutchinson,
Ragnar Martin Joakimsen,
Inger Njølstad,
Henrik Schirmer,
Yngve Anton Figenschau,
Johan Svartberg
et al.:
Effects of Age and Sex on Estimated Diabetes Prevalence Using Different Diagnostic Criteria: The Tromso OGTT Study
International Journal of Endocrinology 2013
ARKIV /
DOI
Rolf Jorde,
Henrik Schirmer,
Inger Njølstad,
Maja-Lisa Løchen,
Ellisiv B. Mathiesen,
Elena Kamycheva
et al.:
Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromso Study
European Journal of Epidemiology (EJE) 2013
DOI
Guri Grimnes,
Ragnar M Joakimsen,
Yngve Figenschau,
Peter A Torjesen,
Bjørg Almås,
Rolf Jorde
:
The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial
Moira Strand Hutchinson,
Ragnar Martin Joakimsen,
Inger Njølstad,
Henrik Schirmer,
Yngve Anton Figenschau,
Rolf Jorde
:
Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study
Journal of Endocrinological Investigation 2012
DOI
Grethe Birketvedt,
Allan Geliebter,
Ingrid Christiansen,
Yngve Anton Figenschau,
Rasmus Goll,
Jon Florholmen
:
Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome
Marie Kjærgaard,
Knut Waterloo,
Catharina E. Wang,
Bjørg Almås,
Yngve Anton Figenschau,
Moira Strand Hutchinson
et al.:
Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial
British Journal of Psychiatry 2012
DOI
Rolf Jorde,
Henrik Schirmer,
Tom Wilsgaard,
Ragnar Martin Joakimsen,
Ellisiv B. Mathiesen,
Inger Njølstad
et al.:
Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study
Martin Polacek,
Jack-Ansgar Bruun,
Jan Elvenes,
Yngve Figenschau,
Inigo Zubiavrre Martinez
:
The secretory profiles of cultured human articular chondrocytes and mesenchymal stem cells: implications for autologous cell transplantation strategies
Cell Transplantation 2011
DOI
Trine B. Haugen,
Toril Tefre,
Gunilla Malm,
Bo AG Jønsson,
Lars Rylander,
Lars Hagmar
et al.:
Differences in serum levels of CB-153 and p,p '-DDE, and reproductive parameters between men living south and north in Norway
Reproductive Toxicology 2011
DOI
Elizabeth Aarag,
Hildegunn Norbakken Granslo,
Trond Flægstad,
Yngve Figenschau,
H Rohde,
I Sadovskaya
et al.:
Staphylococcus epidermidis polysaccharide intercellular adhesin activates complement
FEMS Immunology and Medical Microbiology 2011
DOI
Guri Grimnes,
Yngve Figenschau,
Bjørg Almås,
Rolf Jorde
:
Vitamin D, Insulin Secretion, Sensitivity, and Lipids Results From a Case-Control Study and a Randomized Controlled Trial Using Hyperglycemic Clamp Technique
Moira Strand Hutchinson,
Yngve Figenschau,
Inger Njølstad,
Henrik Schirmer,
Rolf Jorde
:
Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA(1c)). The Tromso Study
Scandinavian Journal of Clinical and Laboratory Investigation 2011
DOI
Hallvard Lilleng,
Karin Louise Abeler,
Stein Harald Johnsen,
Eva Stensland,
Sissel Løseth,
Rolf Jorde
et al.:
Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromso Study
Neuromuscular Disorders 2011
DOI
Moira Strand Hutchinson,
Yngve Anton Figenschau,
Bjørg Almås,
Inger Njølstad,
Rolf Jorde
:
Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes - the Tromsø OGTT Study
International Journal for Vitamin and Nutrition Research 2011
DOI
Vivian Berg,
Baldur Sveinbjørnsson,
Signy Bendiksen,
Jan Brox,
Khaled Meknas,
Yngve Figenschau
:
Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin 21-157
Arthritis Research & Therapy 2010
ARKIV /
DOI
Rolf Jorde,
Yngve Figenschau,
Moira Strand Hutchinson,
Nina Emaus,
Guri Grimnes
:
High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile
European Journal of Clinical Nutrition 2010
DOI
Guri Grimnes,
Nina Emaus,
Ragnar M Joakimsen,
Yngve Figenschau,
Trond Geir Jenssen,
Inger Njølstad
et al.:
Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up
Diabetic Medicine 2010
DOI
Rolf Jorde,
Monica Sneve,
Peter A Torjesen,
Yngve Figenschau,
John-Bjarne Hansen,
Guri Grimnes
:
No significant effect on bone mineral density by high doses of vitamin D-3 given to overweight subjects for one year
Rolf Jorde,
Monica Sneve,
Nina Emaus,
Yngve Figenschau,
Guri Grimnes
:
Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study
European Journal of Nutrition 2010
DOI
Rolf Jorde,
Monica Sneve,
Moira Strand Hutchinson,
Nina Emaus,
Yngve Figenschau,
Guri Grimnes
:
Tracking of Serum 25-Hydroxyvitamin D Levels During 14 Years in a Population-based Study and During 12 Months in an Intervention Study
American Journal of Epidemiology 2010
DOI
Rolf Jorde,
Yngve Figenschau,
Nina Emaus,
Moira Strand Hutchinson,
Guri Grimnes
:
Serum 25-Hydroxyvitamin D Levels Are Strongly Related to Systolic Blood Pressure But Do Not Predict Future Hypertension
Rolf Jorde,
Monica Sneve,
Peter A Torjesen,
Yngve Figenschau,
Lasse G Gøransson,
Roald Omdal
:
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects
Moira Strand Hutchinson,
Guri Grimnes,
Ragnar M Joakimsen,
Yngve Figenschau,
Rolf Jorde
:
Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study
European Journal of Endocrinology (EJE) 2010
DOI
Rolf Jorde,
Monica Sneve,
Peter A Torjesen,
Yngve Figenschau,
John-Bjarne Hansen
:
Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D
Thrombosis Research 2010
DOI
Rolf Jorde,
Monica Sneve,
Peter A Torjesen,
Yngve Figenschau
:
No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D-3 for 1 year
Journal of Internal Medicine 2010
DOI
Guri Grimnes,
Bjørg Almås,
Anne Elise Eggen,
Nina Emaus,
Yngve Figenschau,
Laila Arnesdatter Hopstock
et al.:
Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed
European Journal of Endocrinology (EJE) 2010
DOI
Rolf Jorde,
Yngve Figenschau
:
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels
European Journal of Nutrition 2009
DOI
Monica Sneve,
Yngve Figenschau,
Rolf Jorde
:
Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects
European Journal of Endocrinology (EJE) 2008
DOI
Guri Grimnes,
Nina Emaus,
Ragnar M Joakimsen,
Yngve Figenschau,
Rolf Jorde
:
The Relationship between Serum TSH and Bone Mineral Density in Men and Postmenopausal Women: The Tromso Study
Ann Kristin Hansen,
Yngve Anton Figenschau,
Inigo Zubiavrre Martinez
:
Dynamic expression of VDR and 1alphahydroxylase in differentiated and redifferentiated human articular
chondrocytes
Ann Kristin Hansen,
Jill-Tove Indrevik,
Yngve Anton Figenschau,
Inigo Zubiavrre Martinez,
Baldur Sveinbjørnsson
:
Expression and function of Leukotriene B4 receptors in human articular chondrocytes
Guri Grimnes,
Ragnar M Joakimsen,
Yngve Figenschau,
Peter A Torjesen,
Bjørg Almås,
Rolf Jorde
:
Effect of one year treatment with high dose vitamin d-3 on bone mineral density and bone turnover in postmenopausal women with low bone mass-results from a randomized controlled trial
Osteoporosis International 2011
Magne Arve Flaten,
espen BjØrkedal,
Peter Solvoll Lyby,
Yngve Figenschau,
Per M. Aslaksen
:
GENDER EFFECTS IN CLASSICAL CONDITIONING OF PLACEBO ANALGESIA
2010
Magne Arve Flaten,
Per M. Aslaksen,
espen BjØrkedal,
Yngve Figenschau,
Peter Solvoll Lyby,
Ole Åsli
:
EMOTIONAL FACTORS CONTRIBUTE TO THE REDUCTION OF PAIN AFTER ADMINISTRATION OF A PLACEBO
2010
Linn Hofsøy Steffensen,
Magritt Brustad,
Guri Skeie,
Leif Jørgensen,
Yngve Figenschau,
Margitta Theodora Kampman
:
Vitamin D status in individuals with multiple sclerosis at baseline and after supplementation with 20,000 IU cholecalciferol a week for 48 weeks
Multiple Sclerosis 2009
Hallvard Lilleng,
stein harald Johnsen,
Eva Stensland,
K Abeler,
Sissel Løseth,
Rolf Jorde
et al.:
Creatine kinase (CK) in a normal population: Towards new referent values?
Neuromuscular Disorders 2009
DOI
Hallvard Lilleng,
Eva Stensland,
stein harald Johnsen,
K Abeler,
Sissel Løseth,
Rolf Jorde
et al.:
Prevalence of hyperCKemia in a normal population
European Journal of Neurology 2009
Johannes C Nossent,
Yngve Figenschau,
Cathrin Nikolaisen
:
Anemia in early rheumatoid arthritis is associated with IL-6 mediated bone marrow suppression, but has no impact on disease course or mortality
Scandinavian Journal of Rheumatology 2008